Outlook Therapeutics competitive analysis

Loading summary...

Explore Outlook Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jul 22, 2020Modulation Of Afucosylated Species In A Monoclonal Antibody Composition1

Latest publications and patents of Outlook Therapeutics New

Explore the latest publications and patents granted to Outlook Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Outlook Therapeutics

Jul 22, 2020Modulation Of Afucosylated Species In A Monoclonal Antibody CompositionRevoked

Latest PTAB cases involving Outlook Therapeutics

Discover the latest PTAB cases involving Outlook Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Outlook Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
OUTLOOK THERAPEUTICS - 1 - -
PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBB18 - - -